comparemela.com
  1. Home
  2. Live Updates
  3. Drug Administration For Filspari - Breaking News

Latest Breaking News On - Drug administration for filspari - Page 1 : comparemela.com

Travere drug for rare kidney condition recommended for EU approval

Vifor Pharma and partner Travere Therapeutics on Friday won an endorsement for approval from the European Union s drug regulator for their drug Filspari, part of an industry race to treat a rare,.

Vifor pharmaMark potterEuropean unionEuropean commissionDrug administration for filspariTravere therapeuticsDrug administrationLudwig burger editing

Travere Drug for Rare Kidney Condition Recommended for EU Approval

Vifor Pharma and partner Travere Therapeutics on Friday won an endorsement for approval from the European Union's drug regulator for their drug Filspari, part of an industry.

Ludwig burgerMark potterVifor pharmaEuropean unionEuropean commissionDrug administration for filspariTravere therapeuticsDrug administrationRenal failureEnal insufficiencyIdney insufficiencyKidney failureRenal impairmentVascular accessKidney dialysisEnal dialysis haemodialysis

Travere Shares Rise 8 4%; Co To Cut Staff, Focus on IgAN, HCU Treatments

Travere Shares Rise 8 4%; Co To Cut Staff, Focus on IgAN, HCU Treatments
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Stephen nakrosisDrug administration for filspariDow jones company incTravere therapeuticsDrug administrationDow jones

Travere Shares Rise 8 4%; Co To Cut Staff, Focus on IgAN, HCU Treatments

By Stephen Nakrosis Shares of Travere Therapeutics were trading higher in Monday s after-hours market, following new the company plans to reduce its workforce by about 20% and focus near-term.

Stephen nakrosisDrug administration for filspariTravere therapeuticsDrug administrationDow jones

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.